Buy DocuSign, Sell Crowdstrike


(MENAFN- Baystreet.ca) DocuSign (NASDAQ:DOCU) soared 22% on Sep. 6 after reporting Q2 results. Its upside revenue guidance for Q3 and for FY 2020 are both sharply higher than consensus estimates. The worst is over for DOCU stock.

DocuSign has ~537K customers and a TAM of $25 billion. In Q2, billings grew 47% Y/Y to $252.4 million. For Q3, revenue may top $241 million, up from the $231.9 million consensus estimates. In FY 2020, revenue will be $947M - $951M. Analysts expected $920.4M.

The improved recurring subscription revenue visibility and higher customer base spend are two reasons to buy the stock.

Crowdstrike (NASDAQ:CRWD) is sharply below its $99 highs of August. The company's Q2/2020 report posted on Sept. 5 is a disappointment.

The security firm lost $0.18 a share even though revenue grew 94% Y/Y to $108.1 million. Even though subscription revenue grew 98% and ARR grew 104% to $423.8 million, this is a very expensive SAAS IPO stock.

The subscription revenue growth dropped from 116% last quarter, too. Plus, last week's post-earnings selling volume could continue into the month, pushing the stock to the $60 level. CRWD closed at $76 last week.

Investors may model a deceleration in revenue growth and set a revenue exit multiple as low as 12 times to arrive at a price target in the $55 range.


MENAFN1109201902120000ID1098991491


Baystreet.ca

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.